Grantham, Mayo, Van Otterloo & Co (GMO)’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-274,296	Closed	-$11.6M	–	718
2023 Q2	$11.6M	Buy	+274,296	New	+$11.1M	0.05%	239
2017 Q3	–	Sell	-5,000	Closed	-$293K	–	652
2017 Q2	$293K	Hold	5,000	–	–	﹤0.01%	474
2017 Q1	$229K	Buy	+5,000	New	+$249K	﹤0.01%	504

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s SYNH Position: Q3 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 274,296 shares — an estimated $11.6M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SYNH in Q1 2017 and held it in 3 quarters. The position peaked at $11.6M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 274,296 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $11.6M.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2017 and held it in 3 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Syneos Health, Inc. Class A Common Stock position peaked at $11.6M in Q2 2023.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2023, filed 13 Nov 2023.